Skip to main content
Caplight Logo









Hula Therapeutics

Hula Therapeutics

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://hulatx.com/

Last Round

Seed

Jul 19, 2024

Total Funding Raised

$250,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Hula Therapeutics is a biotechnology company that develops precision immunotherapies for the treatment of solid tumors in children and adults.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CAR-T cell therapyprecision immunotherapysolid tumor treatmentcell therapycancer immunotherapyimmunopeptidomicsprotein engineeringpeptide-centric therapyneuroblastoma treatmentHLA-targeted therapynext-gen CAR-Tpediatric oncologybiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hula Therapeutics Comparables

Compare Hula Therapeutics with similar companies based on industry and business-model similarity.

Hula Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Affini-T Therapeutics
85%
Myrio Therapeutics
83%
A2 Biotherapeutics
76%

Hula Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 19, 2024

Key People

Founding team and executive leadership

Steven Gelone

Founder, President & CEO

Founding Team

Hula Therapeutics Investors

Notable investors and investment history

Hula Therapeutics investors
InvestorRounds
BioAdvance CapitalSeed
Hatch BiofundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2026

    Monthly visitors grew 567% MoM, reaching 1K.

  • Jul 19, 2024

    $250K round led by Hatch Biofund

Hula Therapeutics Filings

Explore SEC and related filing metadata, where available.

Hula Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Hula Therapeutics's valuation, stock price, and market status.

Is Hula Therapeutics a public or private company?

Hula Therapeutics is a private company.

What is the current stock price of Hula Therapeutics?

Hula Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Hula Therapeutics worth (valuation)?

Valuation information for Hula Therapeutics is not publicly available.

Can I buy Hula Therapeutics stock?

Hula Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Hula Therapeutics's last funding round?

Hula Therapeutics's most recent funding round was Seed on July 19, 2024.

Who are the main investors in Hula Therapeutics?

Key investors in Hula Therapeutics include Hatch Biofund.

Will Hula Therapeutics IPO soon?

No public IPO plans have been announced for Hula Therapeutics.

How can I track Hula Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hula Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range4
Year Founded2022
Last FundingJul 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?